The United Steelworkers says it’s running out of patience with US Steel as negotiations over a new labor agreement stretch ...

Pharmaceutical executives say human biology is too complicated for artificial intelligence (AI) to cure disease on its own, ...

With companies including AstraZeneca, Pfizer and Revolution Medicines clamoring to get in on Summit Therapeutics’ ...

Confidential whistleblower reports allege that Western companies offer huge bonuses to Russian middlemen, inflating prices ...

The Saved by the Bell alum revealed that a family member is facing cancer and his wife, Catriona McGinn, has taken on a ...

Mark-Paul Gosselaar wasn’t rooting for a romance between his and Kylie Bunbury’s characters on Pitch, even if viewers wanted ...

AstraZeneca on Sunday released results from the first late-stage trial of a fully owned ADC, showing it reduced the risk of death by 42% in patients with advanced gastric cancer who had been ...

Takeda Pharmaceutical plans to seek regulatory approval in Japan next year for its gastric cancer drug, after it extended overall survival and delayed disease progression in a late-stage study, a ...

By Bhanvi Satija MADRID, Oct 25 (Reuters) - AstraZeneca's experimental drug sone-ve helped patients with advanced stomach cancer who had received at least two prior treatments to live longer than ...

Akeso CEO Michelle Xia, Ph.D., called AstraZeneca’s investment in Summit Therapeutics “a very smart move” because the money can be used to run trials, and the Big Pharma company can benefit from ...

Key points of this article Counting AstraZeneca's official pipeline line by line from Phase I to submission results in 169 lines. Of these, 103 lines (61%) are oncology, and when limited to the 90 ...